Rahmatullah Rahmati, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Salivary Gland Calculi | 3 | 2017 | 16 | 1.630 |
Why?
|
Sialadenitis | 1 | 2022 | 43 | 0.850 |
Why?
|
Xerostomia | 1 | 2022 | 95 | 0.840 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2020 | 40 | 0.750 |
Why?
|
Endoscopy | 5 | 2022 | 1781 | 0.730 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2020 | 4033 | 0.630 |
Why?
|
Tonsillar Neoplasms | 1 | 2014 | 51 | 0.480 |
Why?
|
Salivary Gland Diseases | 1 | 2013 | 37 | 0.450 |
Why?
|
Tonsillectomy | 1 | 2014 | 255 | 0.390 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 2958 | 0.350 |
Why?
|
Nicotine | 1 | 2014 | 681 | 0.350 |
Why?
|
Anesthesia | 1 | 2017 | 1562 | 0.270 |
Why?
|
Otolaryngology | 3 | 2020 | 643 | 0.260 |
Why?
|
Job Application | 2 | 2020 | 39 | 0.240 |
Why?
|
Salivary Ducts | 1 | 2022 | 24 | 0.220 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2020 | 477 | 0.210 |
Why?
|
Smoking Cessation | 1 | 2014 | 2071 | 0.210 |
Why?
|
Personnel Selection | 2 | 2020 | 190 | 0.200 |
Why?
|
Gingival Neoplasms | 1 | 2019 | 22 | 0.180 |
Why?
|
Maxillary Neoplasms | 1 | 2019 | 45 | 0.170 |
Why?
|
Verbal Behavior | 1 | 2021 | 340 | 0.170 |
Why?
|
Palate, Hard | 1 | 2019 | 57 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1108 | 0.170 |
Why?
|
Neck Dissection | 1 | 2019 | 197 | 0.160 |
Why?
|
Salivary Gland Neoplasms | 1 | 2021 | 298 | 0.160 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 155 | 0.150 |
Why?
|
Nuclear Medicine | 1 | 2020 | 233 | 0.150 |
Why?
|
Thyroid Neoplasms | 2 | 2020 | 2282 | 0.140 |
Why?
|
Pharyngeal Diseases | 1 | 2018 | 133 | 0.140 |
Why?
|
Osteoradionecrosis | 1 | 2016 | 49 | 0.140 |
Why?
|
Wound Closure Techniques | 1 | 2016 | 83 | 0.130 |
Why?
|
Pharyngectomy | 1 | 2015 | 45 | 0.130 |
Why?
|
Tumor Burden | 1 | 2020 | 1917 | 0.120 |
Why?
|
Thyroidectomy | 1 | 2020 | 879 | 0.120 |
Why?
|
Osteosarcoma | 1 | 2020 | 881 | 0.120 |
Why?
|
Fistula | 1 | 2016 | 221 | 0.120 |
Why?
|
Lymphoproliferative Disorders | 1 | 2018 | 524 | 0.120 |
Why?
|
Operating Rooms | 1 | 2021 | 817 | 0.120 |
Why?
|
Ophthalmology | 1 | 2020 | 508 | 0.120 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2014 | 73 | 0.120 |
Why?
|
Treatment Outcome | 5 | 2022 | 63042 | 0.110 |
Why?
|
Thyroid Gland | 1 | 2020 | 1173 | 0.110 |
Why?
|
Medical Errors | 1 | 2021 | 1297 | 0.110 |
Why?
|
Neoplasm Staging | 5 | 2021 | 11036 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2014 | 180 | 0.100 |
Why?
|
Free Tissue Flaps | 1 | 2016 | 328 | 0.100 |
Why?
|
Pharynx | 1 | 2014 | 412 | 0.100 |
Why?
|
Anesthesiology | 1 | 2021 | 1060 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 642 | 0.090 |
Why?
|
Internship and Residency | 2 | 2020 | 5787 | 0.090 |
Why?
|
Anesthesia, General | 1 | 2017 | 1171 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2020 | 6356 | 0.090 |
Why?
|
Carcinoma | 1 | 2021 | 2375 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2528 | 0.090 |
Why?
|
Lung Transplantation | 1 | 2018 | 1155 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1533 | 0.080 |
Why?
|
Male | 14 | 2022 | 349776 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1770 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2015 | 1119 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2971 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2021 | 77410 | 0.080 |
Why?
|
Middle Aged | 10 | 2022 | 213241 | 0.080 |
Why?
|
Humans | 22 | 2022 | 743811 | 0.080 |
Why?
|
Papillomavirus Infections | 2 | 2020 | 1587 | 0.080 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 976 | 0.080 |
Why?
|
Students, Medical | 1 | 2020 | 1862 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3748 | 0.070 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3617 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2014 | 1629 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2016 | 2736 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8337 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13273 | 0.060 |
Why?
|
Female | 12 | 2020 | 380020 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2014 | 3476 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3608 | 0.050 |
Why?
|
Sodium Glutamate | 1 | 2021 | 27 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10251 | 0.050 |
Why?
|
Prognosis | 3 | 2021 | 29052 | 0.050 |
Why?
|
United States | 5 | 2020 | 69859 | 0.050 |
Why?
|
Aptitude Tests | 1 | 2020 | 21 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12243 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 40545 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14714 | 0.040 |
Why?
|
Salivary Glands | 1 | 2020 | 229 | 0.040 |
Why?
|
Survival Rate | 3 | 2019 | 12786 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2014 | 13980 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9239 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 9944 | 0.040 |
Why?
|
Smoking | 1 | 2014 | 8984 | 0.040 |
Why?
|
Preoperative Period | 1 | 2019 | 550 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 559 | 0.040 |
Why?
|
Paranasal Sinus Diseases | 1 | 2018 | 116 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2020 | 1035 | 0.040 |
Why?
|
Skull | 1 | 2020 | 812 | 0.030 |
Why?
|
Mandible | 1 | 2020 | 718 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 214 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 609 | 0.030 |
Why?
|
Self Concept | 1 | 2020 | 1024 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2020 | 2883 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2020 | 2538 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23327 | 0.030 |
Why?
|
Neck Pain | 1 | 2014 | 180 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2018 | 847 | 0.030 |
Why?
|
Consensus | 1 | 2020 | 2954 | 0.020 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2014 | 287 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 413 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2014 | 597 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4848 | 0.020 |
Why?
|
Adult | 4 | 2020 | 213889 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2016 | 1275 | 0.020 |
Why?
|
Risk Factors | 1 | 2016 | 72252 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25032 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 2018 | 1178 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8637 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8316 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6750 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20121 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39001 | 0.020 |
Why?
|
Clinical Competence | 1 | 2020 | 4687 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2014 | 1241 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5301 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12954 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57744 | 0.010 |
Why?
|
Aged | 3 | 2019 | 163178 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15281 | 0.010 |
Why?
|
Child | 1 | 2014 | 77637 | 0.000 |
Why?
|